$2.85 Very Clean ABCD Pattern @ ~2 pm LONGPotential Break-Out over day highs at 3.30s Swinging this overnight, the goal is 3.20-3.30
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.5237USD
−36.63 MUSD
13.17 M
About AEON Biopharma, Inc.
Sector
CEO
Marc Forth
Headquarters
Irvine
Website
Employees (FY)
10
Founded
2012
FIGI
BBG00Z17HDW3
AEON Biopharma, Inc. is a biopharmaceutical company. It engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.
Long at 12,14 and target 14.THIS IS NOT SHORT IDEA!!! Expecting a fall to 12,14 and rejection back to the final target. Enter just after clear rejection on 4H chart. Then set conditional SL, if any two 4H candles closes below the SL zone, cutloss your trade. No rejection at 12,14 = no trade. Don´t fall to the trap by buying lo
See all ideas
An aggregate view of professional'sratings.
Frequently Asked Questions
The current price ofAEONis0.9800USD— it hasn't changed in the past 24 hours. WatchAEON Biopharma, Inc.stock price performance more closely on thechart.
Depending on the exchange, the stock ticker may vary. For instance, onAMEXexchangeAEON Biopharma, Inc.stocks are traded under the tickerAEON.
AEONstock has fallen by−2.00% compared to the previous week, the month change is a−58.30% fall, over the last yearAEON Biopharma, Inc.has showed a−75.86% decrease.
We've gathered analysts' opinions onAEON Biopharma, Inc.future price: according to them,AEONprice has a max estimate of5.00USDand a min estimate of5.00USD.WatchAEONchartand read a more detailedAEON Biopharma, Inc.stock forecast:see what analysts think ofAEON Biopharma, Inc.and suggest that you do with its stocks.
AEONstock is2.09% volatile and has beta coefficient of1.71.TrackAEON Biopharma, Inc.stock price on thechartand check out the list of themost volatile stocks— isAEON Biopharma, Inc.there?
TodayAEON Biopharma, Inc.has the market capitalization of38.73 M,it has decreased by−1.98% over the last week.
Yes, you can trackAEON Biopharma, Inc.financialsin yearly and quarterly reports right on TradingView.
AEON Biopharma, Inc.is going to release the next earnings report onNov 11, 2024.Keep track of upcoming events with ourEarnings Calendar.
AEONearnings for the last quarter are4.22USDper share, whereas the estimation was−0.19USDresulting in a2.32 K% surprise. The estimated earnings for the next quarter are−0.16USDper share. See more details aboutAEON Biopharma, Inc.earnings.
AEON Biopharma, Inc.revenuefor the last quarter amounts to0.00USD,matching the estimated figure, and no changes in revenue are expected for the next quarter.
AEONnet income for the last quarter is164.11 MUSD,while the quarter before that showed−118.02 MUSDof net income which accounts for239.06% change. Track moreAEON Biopharma, Inc.financial statsto get the full picture.
No,AEONdoesn't pay any dividends to its shareholders. But don't worry, we've prepared a list ofhigh-dividend stocksfor you.
As ofAug 22, 2024,the company has10.00employees. See our rating of thelargest employees— isAEON Biopharma, Inc.on this list?
Like other stocks,AEONshares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can tradeAEON Biopharma, Inc.stock right from TradingView charts — choose yourbrokerand connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. SoAEON Biopharma, Inc.technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month ratingAEON Biopharma, Inc.stock shows the sell signal. See more ofAEON Biopharma, Inc.technicalsfor a more comprehensive analysis.
If you're still not sure, try looking for inspiration in ourcurated watchlists.
If you're still not sure, try looking for inspiration in ourcurated watchlists.